Rabbit anti-CEACAM1 Recombinant Monoclonal Antibody [BLR090G]
Catalog #
CEACAM1
Human
Flow Cyt
,ICC
,IHC
,IP
,WB
Rabbit
Recombinant Monoclonal
BLR090G
Whole IgG
residues 35-433 (ECD)
IgG
Unconjugated
Purified
Product Details
Human
Human
2 - 8 °C
1 year from date of receipt
Carcinoembryonic antigen related cell adhesion molecules 1 and 5 (CEACAM1 and CEACAM5) are members of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily. CEACAM1 was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. CEACAM5 is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, CEACAM5 may regulate differentiation, apoptosis, and cell polarity.
Carcinoembryonic antigen-related cell adhesion molecule 1
Alternate Names
antigen CD66; BGP; BGP1; BGP-1; BGPI; Biliary glycoprotein 1; carcinoembryonic antigen-related cell adhesion molecule 1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); CD antigen CD66a; CD66a antigen
Applications